Mutations in genes such as EGFR, ALK, and ROS1 are prevalent in younger patients, promoting cell proliferation and tumor growth, while mutations in tumor suppressor genes like BRCA2 and TP53 increase lung cancer susceptibility, particularly in non-smoking individuals [9,11,12]. Here, ALK is linked to neoplasm.